Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$6.56
+1.7%
$6.62
$6.10
$10.03
$14.78B0.15581,381 shs230,954 shs
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$82.78
-0.2%
$81.46
$72.30
$87.89
$47.74B0.874.74 million shs869,764 shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$551.33
-0.4%
$568.24
$496.61
$769.98
$43.48B1.58539,871 shs174,309 shs
Waters Corporation stock logo
WAT
Waters
$338.90
-0.7%
$315.53
$275.05
$414.15
$33.32B1.141.07 million shs177,302 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
+2.54%+2.55%-5.29%-14.34%-33.89%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
+0.87%+1.65%+1.66%+5.10%+6.46%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
+1.30%+4.71%-5.06%-12.23%+7.04%
Waters Corporation stock logo
WAT
Waters
+2.50%+1.91%+1.67%+3.80%-5.80%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$6.56
+1.7%
$6.62
$6.10
$10.03
$14.78B0.15581,381 shs230,954 shs
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$82.78
-0.2%
$81.46
$72.30
$87.89
$47.74B0.874.74 million shs869,764 shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$551.33
-0.4%
$568.24
$496.61
$769.98
$43.48B1.58539,871 shs174,309 shs
Waters Corporation stock logo
WAT
Waters
$338.90
-0.7%
$315.53
$275.05
$414.15
$33.32B1.141.07 million shs177,302 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
+2.54%+2.55%-5.29%-14.34%-33.89%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
+0.87%+1.65%+1.66%+5.10%+6.46%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
+1.30%+4.71%-5.06%-12.23%+7.04%
Waters Corporation stock logo
WAT
Waters
+2.50%+1.91%+1.67%+3.80%-5.80%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
1.50
ReduceN/AN/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
2.79
Moderate Buy$95.6515.56% Upside
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.64
Moderate Buy$751.0036.22% Upside
Waters Corporation stock logo
WAT
Waters
2.75
Moderate Buy$396.0016.85% Upside

Current Analyst Ratings Breakdown

Latest CLPBY, EW, IDXX, and WAT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2026
Waters Corporation stock logo
WAT
Waters
Boost Price TargetEqual Weight$355.00 ➝ $370.00
5/11/2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
DowngradeHold (C+)Hold (C)
5/7/2026
Waters Corporation stock logo
WAT
Waters
Reiterated RatingHold$350.00
5/7/2026
Waters Corporation stock logo
WAT
Waters
Boost Price TargetOverweight$400.00 ➝ $425.00
5/6/2026
Waters Corporation stock logo
WAT
Waters
Boost Price TargetNeutral$330.00 ➝ $375.00
5/6/2026
Waters Corporation stock logo
WAT
Waters
Boost Price TargetHold$345.00 ➝ $385.00
5/6/2026
Waters Corporation stock logo
WAT
Waters
Set Price Target$387.00
5/6/2026
Waters Corporation stock logo
WAT
Waters
Boost Price TargetNeutral$330.00 ➝ $345.00
4/28/2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Lower Price TargetNeutral$730.00 ➝ $640.00
4/27/2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Reiterated RatingHold (C+)
4/27/2026
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Reiterated RatingOverweight$104.00 ➝ $110.00
(Data available from 5/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$4.13B3.58$0.37 per share17.54$1.06 per share6.19
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$6.07B7.86$2.87 per share28.81$17.94 per share4.61
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$4.30B10.11$15.22 per share36.22$19.73 per share27.94
Waters Corporation stock logo
WAT
Waters
$3.17B10.51$16.91 per share20.04$155.74 per share2.18
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$538.49M$0.1446.8615.261.997.46%31.96%10.20%N/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$1.07B$1.8844.1024.712.0617.39%15.19%11.71%7/23/2026 (Estimated)
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$1.06B$13.5840.5933.453.1724.63%70.87%32.56%8/3/2026 (Estimated)
Waters Corporation stock logo
WAT
Waters
$642.63M$7.8743.1120.532.1011.91%15.60%8.90%8/3/2026 (Estimated)

Latest CLPBY, EW, IDXX, and WAT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2026Q2 2026
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.09$0.10+$0.01-$0.07$1.11 billion$1.11 billion
5/5/2026Q1 2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.41$3.47+$0.06$3.47$1.12 billion$1.14 billion
5/5/2026Q1 2026
Waters Corporation stock logo
WAT
Waters
$2.31$2.70+$0.39-$0.87$1.20 billion$1.27 billion
4/23/2026Q1 2026
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.7280$0.78+$0.0520$0.66$1.60 billion$1.65 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.355.34%N/A250.00%N/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
N/AN/AN/AN/AN/A
Waters Corporation stock logo
WAT
Waters
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
1.50
1.30
0.81
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.06
4.42
3.63
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.19
1.12
0.82
Waters Corporation stock logo
WAT
Waters
0.32
1.79
1.13

Institutional Ownership

CompanyInstitutional Ownership
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
N/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
79.46%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
87.84%
Waters Corporation stock logo
WAT
Waters
94.01%

Insider Ownership

CompanyInsider Ownership
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
N/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.31%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.79%
Waters Corporation stock logo
WAT
Waters
0.31%
CompanyEmployeesShares OutstandingFree FloatOptionable
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
17,1562.25 billionN/ANot Optionable
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
16,000575.80 million574.02 millionOptionable
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
11,00078.88 million78.26 millionOptionable
Waters Corporation stock logo
WAT
Waters
7,90098.19 million97.88 millionOptionable

Recent News About These Companies

What Makes Waters Corporation (WAT) an Investment Bet?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Coloplast A/S stock logo

Coloplast A/S OTCMKTS:CLPBY

$6.56 +0.11 (+1.71%)
As of 01:11 PM Eastern

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$82.78 -0.20 (-0.24%)
As of 01:34 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

IDEXX Laboratories stock logo

IDEXX Laboratories NASDAQ:IDXX

$551.33 -2.25 (-0.41%)
As of 01:34 PM Eastern
This is a fair market value price provided by Massive. Learn more.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Waters stock logo

Waters NYSE:WAT

$338.90 -2.42 (-0.71%)
As of 01:34 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.